[登录] [免费注册]
试剂仪器网
发布求购
位置：首页 > 资料中心 > 化工字典 > 75607-67-9
关键词:       仅模糊查询
CAS: 75607-67-9
分子式: C10H13FN5O7P
分子量: 365.21
中文名称: 
磷酸氟达拉滨
英文名称: 
2-fluoro-9-(5-o-phosphono-beta-d-arabinofuranosyl)-9h-purin-6-amin
2-fluoro-9-(5-o-phosphono-beta-d-arabinofuranosyl)-9h-purin-6-amine
2-fluoro-ara amp
9-beta-arabinofuranosyl-2-fluoroadenine-5'-phosphate
9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-monophosphate
fludarabine monophosphate
fludarabine phosphate
nsc-312887
推荐供应商
货号品牌产品名称规格包装、参考价格详情
F810232MACKLIN单磷酸氟达拉滨99%155元/250mg;   599元/1g;   展开
储存：2~8℃
状态：白色到浅黄色粉末
F797012MACKLIN单磷酸氟达拉滨10mM in DMSO369元/1ml;   展开
储存：-20°C
F0913TCIFludarabine Monophosphate>98.0%(T)(HPLC)150元/25MG;   590元/100MG;   展开

基本信息

纯度/分析方法>98.0%(T)(HPLC)
分子式/分子量C10H13FN5O7P = 365.21
外观与形状(20℃)固体
储存在惰性气体下存放于惰性气体之中
应避免的情况湿气 (吸湿)
Reaxys-RN8167686
PubChem物质ID253660324
Merck Index (14)4126
MDL编号MFCD00866418

技术规格

AppearanceWhite to Almost white powder to crystal
Purity(HPLC)min. 98.0 area%
Purity(Neutralization titration)min. 98.0 %
Specific rotation [a]20/D+11.0 to +13.0 deg(C=0.5, H2O)

物性(参考值)

熔点203 ℃(dec.)
比旋光度 [α]D12° (C=0.5,H2O)
水溶性实际上不溶
在水中的溶解度8.9 g/l   20 ℃
溶解性(易溶于)二甲基甲酰胺
溶解性(不溶于)乙醚,乙醇

安全信息

图形或危害标志
信号词警告
危险性说明H302 : 吞咽有害。
H361 : 怀疑对生育能力或胎儿造成伤害。
H362 : 可能对母乳喂养的儿童造成伤害。
H373 : 长期或反复接触可能损害器官。
防范说明P501 : 将内装物/容器送到批准的废物处理厂处理。
P263 : 怀孕/ 哺乳期间避免接触。
P260 : 不要吸入粉尘/ 烟/ 气体/ 烟雾/ 蒸气/ 喷雾。
P270 : 使用本产品时不要进食、饮水或吸烟。
P202 : 在阅读并明了所有安全措施前切勿搬动。
P201 : 使用前取得专用说明。
P264 : 作业后彻底清洗皮肤。
P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。
P308 + P313 : 如接触到或有疑虑：求医/就诊。
P301 + P312 + P330 : 如误吞咽：如感觉不适，呼叫急救中心/医生。漱口。
P405 : 存放处须加锁。

相关法规

RTECS#UO7440900
995541J&KFludarabine Monophosphate98%274元/25MG;   770元/100MG;   展开

基本信息

分子式C10H13FN5O7P
分子量365.22
熔点203
比旋光度([α]20D)+11° to +13° (C=0.5, H2O)
MDL编码MFCD00866418
存储条件Freezer -20℃

安全信息

图形或危害标志
提示语Warning
危险说明H302
H361
H362
H373
防范说明P261
P263
P281
P301+P312
Y0001536Fludarabine for system suitabilityEuropean Pharmacopoeia (EP) Reference Standard1572.27元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C10H13FN5O7P
分子量365.21
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
储存温度2-8℃
InChI1S/C10H13FN5O7P/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,14,15)(H2,19,20,21)
InChI keyGIUYCYHIANZCFB-UHFFFAOYSA-N

安全信息

象形图GHS08
警示用语：Warning
危险声明H341 - H361d
预防措施声明P201 - P202 - P280 - P308 + P313 - P405 - P501
危险分类Muta. 2 - Repr. 2
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0000419Fludarabine phosphateEuropean Pharmacopoeia (EP) Reference Standard1259.15元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 120 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C10H13FN5O7P
分子量365.21
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
储存温度2-8℃
InChI1S/C10H13FN5O7P/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,14,15)(H2,19,20,21)
InChI keyGIUYCYHIANZCFB-UHFFFAOYSA-N

安全信息

象形图GHS08
警示用语：Warning
危险声明H341 - H361d
预防措施声明P201 - P202 - P280 - P308 + P313 - P405 - P501
危险分类Muta. 2 - Repr. 2
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
F9813Sigma-AldrichFludarabine phosphate595.76元/5 MG;   2570.99元/25 MG;   展开

产品说明

一般描述

Fludarabine is a purine analog included in the category of DNA-damaging drugs with well-known efficacy in B-cell chronic lymphocytic leukemia (B-CLL).

生化/生理作用

Fludarabine represses DNA replication and suppresses the nucleotide metabolism by inhibiting the enzyme ribonucleotide reductase.

基本信息

经验(实验)分子式C10H13FN5O7P
分子量365.21
NACRESNA.85

产品性质

形式powder
质量水平200
颜色 white
溶解性DMSO: 1 mg/mL
作用机制DNA synthesis | interferes
抗生素抗菌谱neoplastics
储存温度−20℃
InChI1S/C10H13FN5O7P/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,14,15)(H2,19,20,21)
InChI keyGIUYCYHIANZCFB-UHFFFAOYSA-N

安全信息

象形图GHS08
警示用语：Warning
危险声明H341 - H361d
预防措施声明P201 - P202 - P280 - P308 + P313 - P405 - P501
危险分类Muta. 2 - Repr. 2
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0002256Fludarabine for peak identificationEuropean Pharmacopoeia (EP) Reference Standard1341.2元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C10H13FN5O7P
分子量365.21

产品性质

manufacturer/tradenameEDQM
储存温度2-8℃
InChI1S/C10H13FN5O7P/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,14,15)(H2,19,20,21)
InChI keyGIUYCYHIANZCFB-UHFFFAOYSA-N

安全信息

象形图GHS08
警示用语：Warning
危险声明H341 - H361d
预防措施声明P201 - P202 - P280 - P308 + P313 - P405 - P501
危险分类Muta. 2 - Repr. 2
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
1272204USPFludarabine phosphateUnited States Pharmacopeia (USP) Reference Standard3231.47元/300 MG;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他说明

USP issued SDS can be found here.
Sales restrictions may apply.

基本信息

经验(实验)分子式C10H13FN5O7P
分子量365.21
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameUSP
application(s)pharmaceutical (small molecule)
格式neat
储存温度2-8℃
InChI1S/C10H13FN5O7P/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,14,15)(H2,19,20,21)
InChI keyGIUYCYHIANZCFB-UHFFFAOYSA-N

安全信息

象形图GHS08
警示用语：Warning
危险声明H341 - H361d
预防措施声明P201 - P202 - P280 - P308 + P313 - P405 - P501
危险分类Muta. 2 - Repr. 2
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
CAS号首数字顺序排列： 1 2 3 4 5 6 7 8 9